Ignite Creation Date:
2024-05-06 @ 5:04 PM
Last Modification Date:
2024-10-26 @ 2:21 PM
Study NCT ID:
NCT05186545
Status:
RECRUITING
Last Update Posted:
2022-09-02
First Post:
2021-12-23
Brief Title:
An Exploratory Study of Surufatinib Combined With Chidamide and Fulvestrant in HR Positive Unresectable Metastatic Breast Cancer
Sponsor:
The First Affiliated Hospital of Zhengzhou University
Organization:
The First Affiliated Hospital of Zhengzhou University
Organization Data
Organization:
The First Affiliated Hospital of Zhengzhou University
Class:
OTHER
Study ID:
HMPL-012-SPRING-R101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The First Affiliated Hospital of Zhengzhou University
Lead Sponsor Class:
OTHER
Responsible Party:
Hong Zong
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
The First Affiliated Hospital of Zhengzhou University
Old Name:
None
Old Organization:
None